生化科技的先進地區叢集與新興地區叢集 是由出版商Business Insights在2011年09月所出版的。
這份英文市場調查報告書包含Pages: 218 價格從美金4795起跳。
美國由於具有政府的豐富資金提供和成熟的VC部門，優惠的政策，較高的企業文化等，被認為是領導全球生化科技研究的國家。特別是舊金山，聖地牙哥 ，波士頓3大地區的叢集大大超越其他先進地區叢集。另一方面，新興地區叢集澳洲的墨爾本得到很高的評價。
本報告提供生化科技產業趨勢的地區叢集單位相關調查分析，生化科技產業分析的叢集化方法的優點，地區叢集的市場區隔(先進地區叢集·新興地區叢集)和各種的主要地區叢集簡介(總計41個地區叢集)，成功的地區叢集環境，生化科技R&D趨勢與叢集單位的趨勢等彙整資料，為您概述為以下內容。
摘要整理
關於作者
簡介:生化科技叢集的概念
- 摘要
- 簡介
- 叢集定義
- 生化科技產業的叢集方法的優點
- 導致成功的生化科技叢集的組成因素
- 強力的科學基礎
- 企業文化
- 強力的企業基礎
- 有效的科學網路和商務網路
- 吸引人才的能力
- 有效的融資機制
- 強力的基本設備&商務支援服務
- 帶來良好效果的相關法規·智慧財產權環境
- 政策上的支援環境
生化科技研究的主要趨勢
- 摘要
- 簡介
- 製藥企業趨勢
- 研究部門趨勢
- 西洋地區的叢集為主流,不過，新興地區叢集具有強力的利基
- 罕見疾病的研究的重要性提高
- 新興各國對局部發病就可以知道疾病的重新關注
- 叢集趨勢
- 經由叢集的發展中的生化科技產業的政府的方法
- 新興企業特別困難的VC資金的進入
- 許多新興叢集的相關法規上的競爭的排除
- 技術轉移的投資和商業化的機制
生化科技的先進地區叢集
- 摘要
- 簡介
- 先進地區叢集的前10名
- 詳細內容叢集簡介
- 美國
- 加拿大
- 德國
- 瑞士
- 英國
- 法國
- 瑞典
- 比利時
- 以色列
- 日本
生化科技的新興地區叢集
- 摘要
- 簡介
- 新興叢集的前10名
- 詳細內容叢集簡介
- 巴西
- UAE
- 韓國
- 紐西蘭
- 澳洲
- 新加坡
- 中國
- 台灣
- 俄羅斯
- 印度
- 馬來西亞
總論
附錄
Description
INTRODUCTION
There has been widespread interest in establishing geographically focused clusters of biotechnology companies and related organizations. It is important for all stakeholders to understand the capabilities of different clusters across the world. Careful alignment of location strategies with the strengths of the various clusters ensures that maximum value can be derived from participation.
FEATURES AND BENEFITS
- Understand the key components of a successful biotech cluster and the prevailing trends in biotech research that influence how clusters operate.
- Gain an overview of key decision making criteria when developing location strategies for research and development.
- Compare the most prominent areas of expertise within different clusters across the world and identify core strengths.
- Assess detailed profiles of 41 clusters in both established and emerging locations, and identify key participants and funding sources.
- View how clusters rank when scored by patenting activity, publications, company presence, industry-academia partnerships, and policy environment.
HIGHLIGHTS
The plentiful government funding, the mature VC sector, the favorable policy environment, and the strong entrepreneurial culture all make the US a leading destination for biotechnology research. The top three US clusters - namely San Francisco, San Diego, and Boston - outscore the rest of the established biotech clusters by a large margin.
Among the emerging clusters, Australia's Melbourne cluster (ranked 24th overall) dominates the group, based on its favorable policy and regulatory environment, especially in clinical trials. The Melbourne cluster has also seen a high amount of collaborative activity with international pharmaceutical companies.
VC funding is becoming difficult to obtain, especially for early stage companies. The total innovation capital decreased to $11.3bn in 2010, down by 19% compared with 2006. In addition, the upfront payment components of these financings have reduced by more than 54%, further shrinking the innovation capital available to start-up companies.
YOUR KEY QUESTIONS ANSWERED
- How do the many biotech clusters of the world compare when ranked against each other?
- What are the key criteria that should be considered when choosing a location to conduct research in specific areas of drug discovery?
- What are the crucial components of a successful biotechnology cluster and what characteristics have led to serial innovation?
- What are the typical commercial rental rates likely to be charged within various biotech clusters across the world?
- Which are the most important academic institutions and companies in a particular region that present attractive opportunities for collaboration?
Table of Contents
Executive Summary
- Introduction to the biotech cluster concept
- Key trends in biotechnology research
- Established biotech clusters
- Emerging biotech clusters
About the author
Introduction to the biotech cluster concept
- Summary
- Introduction
- Definition of a cluster
- Advantages of the cluster approach in biotechnology
- Productivity advantages
- Innovation advantages
- New business establishment advantages
- Components of a successful biotech cluster
- Strong science base
- Entrepreneurial culture
- Strong base of companies
- Effective scientific and business networks
- Ability to attract a skilled workforce
- Effective financing mechanisms
- Strong infrastructure and business support services
- Conducive regulatory and intellectual property environment
- Supportive policy environment
Key trends in biotechnology research
- Summary
- Introduction
- Pharmaceutical organization trends
- Diversification of R&D
- Exploitation of academic resources in a strategic manner
- Research area trends
- Western clusters dominate, but emerging clusters have niche strengths
- Increasing importance of rare disease research
- Refocused attention on diseases of local relevance in emerging countries
- Cluster trends
- Governmental approaches to developing biotech industries via clusters
- Access to VC funding particularly difficult for early-stage companies
- Removal of regulatory hurdles in many emerging clusters
- Investment in technology transfer and commercialization mechanisms
Established biotech clusters
- Summary
- Introduction
- Top 10 established biotech clusters
- Detailed cluster profiles
US
- Canada
- Germany
- Switzerland
UK
- France
- Sweden
- Belgium
- Israel
- Japan
Emerging biotech clusters
- Summary
- Introduction
- Top 10 emerging biotech clusters
- Detailed cluster profiles
- Brazil
- United Arab Emirates (UAE)
- South Korea
- New Zealand
- Australia
- Singapore
- China
- Taiwan
- Russia
- India
- Malaysia
Conclusions
Appendix
- Scope
- Selection of clusters
- Geographical limit of clusters
- Definition of biotechnology
- Methodology
- Patenting activity score
- Publication score
- MeSH terms included for publication search in PubMed
- Company presence score
- Industry-academia partnership score
- Regulatory and policy environment score
- Full list of clusters assessed
- Abbreviations
- Bibliography/References
- Chapter 1 Introduction to the biotech cluster concept
- Chapter 2 Key trends in biotechnology research
- Chapter 3 and Chapter 4 biotech cluster profiles
